This observation was confirmed in 2019, by Xu Y, who reported that PD-L1 expression on tumoral cells was as an independent prognostic factor for OS (HR=2.55, p =0.017) in a population of 60 SCLC patients. The gene discussed is CD274; the disease is small cell lung carcinoma.